Last reviewed · How we verify
Periprocedural Antibiotics
Periprocedural Antibiotics is a Antibiotic prophylaxis (class varies by specific agent used) Small molecule drug developed by Vanderbilt University Medical Center. It is currently FDA-approved for Surgical site infection prophylaxis in general surgery, Surgical site infection prophylaxis in orthopedic procedures, Surgical site infection prophylaxis in cardiac surgery. Also known as: trimethoprim/sulfamethoxazole.
Periprocedural antibiotics prevent surgical site infections by providing antimicrobial coverage during and immediately after medical procedures.
Periprocedural antibiotics prevent surgical site infections by providing antimicrobial coverage during and immediately after medical procedures. Used for Surgical site infection prophylaxis in general surgery, Surgical site infection prophylaxis in orthopedic procedures, Surgical site infection prophylaxis in cardiac surgery.
At a glance
| Generic name | Periprocedural Antibiotics |
|---|---|
| Also known as | trimethoprim/sulfamethoxazole |
| Sponsor | Vanderbilt University Medical Center |
| Drug class | Antibiotic prophylaxis (class varies by specific agent used) |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Surgical Prophylaxis |
| Phase | FDA-approved |
Mechanism of action
Periprocedural antibiotics are administered before, during, or shortly after surgical or invasive procedures to achieve adequate tissue and serum concentrations at the time of incision, reducing the risk of surgical site infections (SSIs). The timing and choice of antibiotic depend on the procedure type, patient risk factors, and local resistance patterns. These are standard prophylactic measures rather than a single drug entity.
Approved indications
- Surgical site infection prophylaxis in general surgery
- Surgical site infection prophylaxis in orthopedic procedures
- Surgical site infection prophylaxis in cardiac surgery
- Surgical site infection prophylaxis in vascular surgery
Common side effects
- Allergic reaction (rash, urticaria)
- Gastrointestinal disturbance (nausea, diarrhea)
- Anaphylaxis (with beta-lactams)
- Clostridioides difficile infection
Key clinical trials
- Nursing Intervention Guided by an ICD Nursing Guideline (NA)
- Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Periprocedural Antibiotics CI brief — competitive landscape report
- Periprocedural Antibiotics updates RSS · CI watch RSS
- Vanderbilt University Medical Center portfolio CI
Frequently asked questions about Periprocedural Antibiotics
What is Periprocedural Antibiotics?
How does Periprocedural Antibiotics work?
What is Periprocedural Antibiotics used for?
Who makes Periprocedural Antibiotics?
Is Periprocedural Antibiotics also known as anything else?
What drug class is Periprocedural Antibiotics in?
What development phase is Periprocedural Antibiotics in?
What are the side effects of Periprocedural Antibiotics?
Related
- Drug class: All Antibiotic prophylaxis (class varies by specific agent used) drugs
- Manufacturer: Vanderbilt University Medical Center — full pipeline
- Therapeutic area: All drugs in Infectious Disease / Surgical Prophylaxis
- Indication: Drugs for Surgical site infection prophylaxis in general surgery
- Indication: Drugs for Surgical site infection prophylaxis in orthopedic procedures
- Indication: Drugs for Surgical site infection prophylaxis in cardiac surgery
- Also known as: trimethoprim/sulfamethoxazole
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing